My Site 7 Group

The Formulation Development Outsourcing Market is experiencing increasing demand, driven by several macro and industry-specific factors. The growing global burden of chronic diseases, including cancer, diabetes, and cardiovascular conditions, has created an urgent need for advanced formulations and faster drug development cycles.

Additionally, patent expirations are fueling generic and biosimilar launches, pushing companies to outsource formulation work to remain competitive. The rising costs of in-house development also play a key role, making outsourcing an attractive alternative.

Emerging markets are witnessing a surge in demand due to cost efficiency and availability of skilled expertise. With personalized medicine and biologics gaining prominence, outsourcing partners are becoming integral to addressing the rising complexities in drug formulations worldwide.